Home › Depression › Connecticut
Depression clinical trials in Connecticut
15 studies for Depression are looking for participants at sites in Connecticut.
Cities in Connecticut
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
- Yale University, New Haven
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Sep 28, 2026 · NCT07610369A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Yale School of Medicine - Yale Program for Psychedelic Science, New Haven
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 25, 2026 · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Cromwell
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 14, 2026 · NCT07065240PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
- Mood Institute, Milford
- Yale School of Medicine, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06713616A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Institute of Living, Hartford
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Sep 8, 2026 · NCT07076407A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Yale University School of Medicine, New Haven
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 6, 2026 · NCT07412756E-Mindfulness Approaches for Living After Breast Cancer
- Stamford Hospital/Bennett Cancer Center, Stamford
RecruitingPhase 3
Ages 18 to 50 · All sexes · Updated Aug 4, 2026 · NCT06748222A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Ct Clinical Research Associates, Cromwell
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Aug 3, 2026 · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cromwell
- Neurocrine Clinical Site, Farmington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT06966401Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
- Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine,, West Haven
RecruitingPhase 1Healthy volunteers welcome
Ages 21 to 65 · All sexes · Updated Jun 16, 2026 · NCT06671977Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life
- Yale University, New Haven
RecruitingHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated May 29, 2026 · NCT05810259The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
- VA Connecticut Healthcare System, West Haven
RecruitingPhase 2
Ages 21 to 65 · All sexes · Updated May 6, 2026 · NCT05786066Stress and Pain in People Living With HIV
- The Yale Stress Center, New Haven
RecruitingHealthy volunteers welcome
Ages 18 to 68 · All sexes · Updated Apr 27, 2026 · NCT06784908External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
- https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceL, Darien
RecruitingObservational study
Ages 18 to 44 · Women · Updated Apr 15, 2026 · NCT06788977Open-Label Psilocybin Study in Transdiagnostic Population
- Connecticut Mental Health Center - Yale School of Medicine, New Haven
RecruitingPhase 1Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT06442423From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.